A phase I/II trial of trifluridine/tipiracil in combination with irinotecan in patients with advanced gastric cancer refractory to fluoropyrimidine, platinum, and taxane.

Hiroki Hara,Takuro Mizukami,Keiko Minashi,Tomohiro Nishina,Naoki Takahashi,Yusuke Amanuma,Akio Nakasha,Masaki Takahashi,Takako Eguchi Nakajima

A phase I/II trial of trifluridine/tipiracil in combination with irinotecan in patients with advanced gastric cancer refractory to fluoropyrimidine, platinum, and taxane.

2021

Hiroki Hara
Takuro Mizukami
Keiko Minashi
Tomohiro Nishina
Naoki Takahashi
Yusuke Amanuma
Akio Nakasha
Masaki Takahashi
Takako Eguchi Nakajima

210Background: Trifluridine/tipiracil (FTD/TPI) or irinotecan is a treatment option in the heavily pretreated patients with advanced gastric cancer (AGC) with the limited efficacy. Thus, we investi...

Keywords:

Oncology
Taxane
Trifluridine
Medicine
Internal medicine
Irinotecan
Refractory
in patient
advanced gastric cancer
phase i ii
Tipiracil

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations